Items where contributor is "Geurts, Jeroen"

Article

Mündermann, Annegret and Geurts, Jeroen and Hügle, Thomas and Nickel, Thomas and Schmidt-Trucksäss, Arno and Halle, Martin and Hanssen, Henner. (2017) Marathon performance but not BMI affects post-marathon pro-inflammatory and cartilage biomarkers. Journal of sports sciences, 35 (7). pp. 711-718.

Bocelli-Tyndall, C. and Trella, E. and Frachet, A. and Zajac, P. and Pfaff, D. and Geurts, J. and Heiler, S. and Barbero, A. and Mumme, M. and Resink, T. J. and Schaeren, S. and Spagnoli, G. C. and Tyndall, A.. (2015) FGF2 induces RANKL gene expression as well as IL1beta regulated MHC class II in human bone marrow-derived mesenchymal progenitor stromal cells. Annals of the rheumatic diseases, Vol. 74, H. 1. pp. 260-266.

Bourgine, P. and LeMagnen, C. and Pigeot, S. and Geurts, J. and Scherberich, A. and Martin, I.. (2014) Combination of immortalization and inducible death strategies to generate a human mesenchymal stromal cell line with controlled survival. Stem Cell Research, 12 (2). pp. 584-598.

Fischer, J. and Geurts, J. and Valderrabano, V. and Hugle, T.. (2013) Educational quality of YouTube videos on knee arthrocentesis. Journal of clinical rheumatology, Vol. 19, H. 7. pp. 373-376.

Geurts, J. and Vermeij, E. A. and Pohlers, D. and Arntz, O. J. and Kinne, R. W. and van den Berg, W. B. and van de Loo, F. A.. (2011) A novel Saa3-promoter reporter distinguishes inflammatory subtypes in experimental arthritis and human synovial fibroblasts. Annals of the Rheumatic Diseases, 70 (7). pp. 1311-1319.

Geurts, J. and van den Brand, B. T. and Wolf, A. and Abdollahi-Roodsaz, S. and Arntz, O. J. and Kracht, M. and van den Berg, W. B. and van de Loo, F. A.. (2011) Toll-like receptor 4 signalling is specifically TGF-beta-activated kinase 1 independent in synovial fibroblasts. Rheumatology, 50 (7). pp. 1216-1225.

van Lent, P. L. and Grevers, L. C. and Schelbergen, R. and Blom, A. and Geurts, J. and Sloetjes, A. and Vogl, T. and Roth, J. and van den Berg, W. B.. (2010) S100A8 causes a shift toward expression of activatory Fcgamma receptors on macrophages via toll-like receptor 4 and regulates Fcgamma receptor expression in synovium during chronic experimental arthritis. Arthritis & Rheumatism, 62 (11). pp. 3353-3364.

Arntz, O. J. and Geurts, J. and Veenbergen, S. and Bennink, M. B. and van den Brand, B. T. and Abdollahi-Roodsaz, S. and van den Berg, W. B. and van de Loo, F. A.. (2010) A crucial role for tumor necrosis factor receptor 1 in synovial lining cells and the reticuloendothelial system in mediating experimental arthritis. Arthritis Research and Therapy, 12 (2). R61.

Geurts, J. and Joosten, L. A. and Takahashi, N. and Arntz, O. J. and Gluck, A. and Bennink, M. B. and van den Berg, W. B. and van de Loo, F. A.. (2009) Computational design and application of endogenous promoters for transcriptionally targeted gene therapy for rheumatoid arthritis. Molecular Therapy, 17 (11). pp. 1877-1887.

Blom, A. B. and Brockbank, S. M. and van Lent, P. L. and van Beuningen, H. M. and Geurts, J. and Takahashi, N. and van der Kraan, P. M. and van de Loo, F. A. and Schreurs, B. W. and Clements, K. and Newham, P. and van den Berg, W. B.. (2009) Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: prominent role of Wnt-induced signaling protein 1. Arthritis & Rheumatism, 60 (2). pp. 501-512.

Geurts, J. and Arntz, O. J. and Bennink, M. B. and Joosten, L. A. and van den Berg, W. B. and van de Loo, F. A.. (2007) Application of a disease-regulated promoter is a safer mode of local IL-4 gene therapy for arthritis. Gene Therapy, 14 (23). pp. 1632-1638.

van de Loo, F. A. and Geurts, J. and van den Berg, W. B.. (2006) Gene therapy works in animal models of rheumatoid arthritis...so what! Current Rheumatology Reports, 8 (5). pp. 386-393.

Roelofs, M. F. and Boelens, W. C. and Joosten, L. A. and Abdollahi-Roodsaz, S. and Geurts, J. and Wunderink, L. U. and Schreurs, B. W. and van den Berg, W. B. and Radstake, T. R.. (2006) Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis. Journal of Immunology, 176 (11). pp. 7021-7027.